A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to assess the relative biological availability and the effect of food on the drug levels of Danicamtiv in health adults.

Key facts

Study ID

NCT06027437

Run by

Bristol-Myers Squibb

People needed

21

Starts

2023-09-05

Expected to finish

2023-11-10

Last updated by the study team

2023-11-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Body mass index (BMI) of 18.0 kg/m2 to 30.0 kg/m2 inclusive
• Participants with resting heart rate ≥ 55 bpm
• Seasonal allergies that do not require medication at the time of the study are acceptable

You may not qualify if…

• Any acute or chronic medical illness
• Head injury, intracranial tumor, or aneurysm within 2 years prior to screening
• History of chronic gastrointestinal disorders or gastrointestinal (GI) surgery (including cholecystectomy) that could impact on drug and food absorption and/or drug excretion

Where it is running

• Anaheim Clinical Trials — Anaheim, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.